Isoproterenol or isoprenaline is a type of non-selective beta adrenoceptor agonist generally used in treatment of bradycardia, heart block and rarely in asthma. Isoproterenol is also used in bronchospasm cases that occur during anesthesia. Isoproterenol usually given at low doses initially and gradually increased. Isoprenaline is given by bolus intravenous injection, intramuscular, subcutaneous routes. In case of emergencies the drug is administered by intracardiac route. The side effects of isoproterenol include, dizziness, tachycardia, and dyspnea.
MARKET DYNAMICS
The key market drivers for Isoproterenol Market Includes, rise in cases of cardiovascular disorders such as bradycardia, stroke, and heart block. Moreover, rise in geriatric population globally along with respiratory issues in elderly population is also fueling market growth. However, adequate side effects from drug such as, tachycardia, dizziness etc. is expected to impede market growth during the forecast period.
MARKET SCOPE
The "Isoproterenol Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Isoproterenol market with detailed market segmentation by type and application. The Isoproterenol Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Isoproterenol Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Isoproterenol Market is segmented on the basis of type and application. On the basis of type the market is segmented as, injection, aerosol, solution. And on the basis of application the market is segmented as, bradycardia, asthma, heart block.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Isoproterenol Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Isoproterenol Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Isoproterenol Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Isoproterenol Market in these regions.
MARKET PLAYERS
The report covers key developments in the Isoproterenol Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Isoproterenol Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Isoproterenol market in the global market. Below mentioned is the list of few companies engaged in the Isoproterenol Market.
The report also includes the profiles of key players in Isoproterenol Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Sanofi Aventis
- HOSPIRA
- NEXUS PHARMAACEUTICALS
- Amneal Pharmaceuticals, Inc
- LGM Pharma
- Cipla
- Recipharm AB
- Triveni Interchem
- AMPHASTAR PHARMACEUTICALS
- Biophore
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.